Approved bactericidal agent, highly effective against multidrug resistant tuberculosis
Highly effective(92%) against M. pneumoniae, C. pneumoniae, & Legionella species than standard therapy (usually a beta-lactam with or without a macrolide) (87%) responsible for pneumonia
Well tolerated & efficacious in the treatment of skin and soft tissue infections caused by staphylococci & streptococci
Shows significant reduction in ruinary tract infections (UTIs) & acute pyelonephritis (APN) in renal transplant recpient.
Dosage:
Lower respiratory tract infections: 400 mg twice daily for 7-10 days Uncomplicated urethral & cervcal gonorrhea: A single doses of 400 mg Urethritis & Cervicitis due to C. trachomatis: 600 mg daily in divided dosage for upto 7 days